Full-Time

Senior OR Executive Director

Medical Information

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Biotechnology
Healthcare

Compensation Overview

$230k - $290kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • Doctoral level degree (Ph.D., Pharm.D., or M.D.) in life sciences with minimum of 5 years bio-pharmaceutical medical information industry experience within Medical or Clinical Affairs
  • Excellent written and verbal communication skills, with the ability to understand and effectively communicate complex scientific and clinical data to internal and external stakeholders
  • Prior Oncology experience preferred
  • Experience in Medical Information, Medical Communications, and Pharmacovigilance
  • Ability to collaborate internally and build solid working relationships cross-functionally
  • Highly organized with the ability to manage multiple projects simultaneously, think critically, and adhere to tight deadlines.
  • Demonstrated functional knowledge of applicable guidelines including ICMJE, ACCME, OIG, PhRMA, GPP & GCP
Responsibilities
  • Lead and expand the Medical Information Call Center in collaboration with Safety and Pharmacovigilance, Quality, Commercial (Marketing and Operations), Product Complaints, and Product Replacements. In addition, this position will be responsible for the oversight of the vendors engaged in these activities.
  • Develops stand process related to Medical Information services
  • Independently creates new Standard Responses (SRs) and updates existing SRs based on an understanding of in-house data and the medical literature
  • Supports Promotional/Medical Review Committee meetings by participating in the review and approval of promotional/medical materials to ensure medical accuracy.
  • Become a subject matter expert and internal liaison for oncology and marketed and pipeline products
  • Lead and manage the execution of the medical information strategies for oncology, with an understanding of how these activities support the overall Medical Affairs Plan in alignment with the Brand strategy
  • Lead and manage medical affairs pharmacovigilance and literature monitoring including literature safety monitoring for our oncology products as well as providing literature updates and annotated summaries of key articles
  • Trains sales team on Medical Information processes.
  • Ensure the delivery of high-quality, fair-balanced, scientifically/clinically accurate medical information and communications deliverables in accordance with established timelines, compliance guidelines/policies, and budgets
  • Performs critical analysis and synthesis of internal/external literature.
  • Provides coverage for the Medical Information booth at US and International medical conferences.
  • Lead special projects as needed

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on research, development, and commercialization of these products, ensuring they meet strict regulatory standards for quality and efficacy. Coherus aims to improve patient lives by expanding access to essential biologic treatments, helping to offset rising healthcare costs. Their business model allows them to generate revenue through the sale of these cost-effective alternatives, giving them a competitive advantage in the biopharmaceutical market.

Company Stage

IPO

Total Funding

$114.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-8%

1 year growth

-13%

2 year growth

-20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Global biosimilars market projected to grow at 24.7% CAGR from 2023 to 2030.
  • FDA guidance on biosimilar interchangeability enhances market acceptance and adoption.
  • Partnerships with research institutes expand treatment options and clinical trial advancements.

What critics are saying

  • Increased competition from Sandoz may impact market share and pricing strategies.
  • 30% staff reduction could lead to operational challenges and pipeline management issues.
  • Divestment of Canadian rights to Toripalimab may limit market presence in Canada.

What makes Coherus BioSciences unique

  • Coherus focuses on cost-effective biosimilars for oncology and inflammatory diseases.
  • The company emphasizes high-quality biologic therapeutics with rigorous regulatory approval.
  • Coherus collaborates with research institutes for novel drug combinations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA